Literature DB >> 9501294

Elevated amniotic fluid nitric oxide metabolites and interleukin-6 in intra-amniotic infection.

C D Hsu1, E Meaddough, S F Hong, K Aversa, L C Lu, J A Copel.   

Abstract

OBJECTIVE: To compare amniotic fluid nitric oxide metabolites and interleukin-6 (IL-6) concentrations in patients with and without intra-amniotic infection.
METHODS: Amniotic fluid nitric oxide metabolites, IL-6, Gram stains, glucose, leukocyte counts, leukocyte esterase activity, creatinine, pH, and specific gravity were determined in 14 patients with intra-amniotic infection and 26 patients without intra-amniotic infection. Intra-amniotic infection was defined as the presence of a positive amniotic fluid culture. The nitric oxide metabolites, nitrate and nitrite (NOx), were measured using Greiss reagent after reduction of nitrate to nitrite with aspergillus nitrate reductase. Interleukin-6 was measured by a two-site, enzyme-linked immunosorbent assay. Amniotic fluid nitric oxide metabolites and IL-6 concentrations were normalized by amniotic fluid creatinine levels. The Mann-Whitney U test, contingency table method, and Spearman's rank correlation test were used for statistical analyses.
RESULTS: Amniotic fluid NOx and IL-6 levels were significantly higher in patients with intra-amniotic infection than in those without intra-amniotic infection (NOx: median = 2.06 mumol/mg creatinine, range = 0.74-6.81 versus 1.35 mumol/mg creatinine, range = 0.99-1.60, P = .01, IL-6: median = 2.00 micrograms/mg creatinine, range = 0.026-4.07 versus median = 0.04 micrograms/mg creatinine, range = 0.004-3.210, P = .0009, respectively). Patients with intra-amniotic infection had significantly elevated leukocyte counts, leukocyte esterase activity, Gram positive stains, and significantly lower amniotic fluid glucose levels compared with those without intra-amniotic infection. There were no differences in gestational age, maternal age, parity, race, pH, or specific gravity between the two groups. Amniotic fluid NOx was significantly correlated with IL-6 (r = .4, P = .02). Both amniotic fluid NOx and IL-6 were also positively correlated with amniotic fluid leukocyte counts, leukocyte esterase activity and Gram stains, and negatively correlated with glucose levels.
CONCLUSIONS: Amniotic fluid NOx and IL-6 are significantly elevated and positively correlated during intra-amniotic infection. Both increased amniotic fluid IL-6 and nitric oxide may exert cytotoxic and cytostatic effects on the target cells. We suggest that measurements of amniotic fluid NOx and IL-6 may serve as useful clinical markers in patients with intra-amniotic infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9501294     DOI: 10.1016/s1071-5576(97)00099-3

Source DB:  PubMed          Journal:  J Soc Gynecol Investig        ISSN: 1071-5576


  9 in total

1.  The diagnostic performance of the Mass Restricted (MR) score in the identification of microbial invasion of the amniotic cavity or intra-amniotic inflammation is not superior to amniotic fluid interleukin-6.

Authors:  Roberto Romero; Nicholas Kadar; Jezid Miranda; Steven J Korzeniewski; Alyse G Schwartz; Piya Chaemsaithong; Wade Rogers; Eleazar Soto; Francesca Gotsch; Lami Yeo; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2013-12-16

2.  Evidence that antibiotic administration is effective in the treatment of a subset of patients with intra-amniotic infection/inflammation presenting with cervical insufficiency.

Authors:  Kyung Joon Oh; Roberto Romero; Jee Yoon Park; JoonHo Lee; Agustin Conde-Agudelo; Joon-Seok Hong; Bo Hyun Yoon
Journal:  Am J Obstet Gynecol       Date:  2019-03-28       Impact factor: 8.661

3.  A novel molecular microbiologic technique for the rapid diagnosis of microbial invasion of the amniotic cavity and intra-amniotic infection in preterm labor with intact membranes.

Authors:  Roberto Romero; Jezid Miranda; Tinnakorn Chaiworapongsa; Piya Chaemsaithong; Francesca Gotsch; Zhong Dong; Ahmed I Ahmed; Bo Hyun Yoon; Sonia S Hassan; Chong Jai Kim; Steven J Korzeniewski; Lami Yeo
Journal:  Am J Reprod Immunol       Date:  2014-01-13       Impact factor: 3.886

4.  Human β-defensin-3 participates in intra-amniotic host defense in women with labor at term, spontaneous preterm labor and intact membranes, and preterm prelabor rupture of membranes.

Authors:  Robert Para; Roberto Romero; Derek Miller; Bogdan Panaitescu; Aneesha Varrey; Tinnakorn Chaiworapongsa; Sonia S Hassan; Chaur-Dong Hsu; Nardhy Gomez-Lopez
Journal:  J Matern Fetal Neonatal Med       Date:  2019-04-18

Review 5.  Cytokines and other important inflammatory mediators in gestation and bacterial intraamniotic infections.

Authors:  I Splíchal; I Trebichavský
Journal:  Folia Microbiol (Praha)       Date:  2001       Impact factor: 2.099

6.  Fetal death: an extreme manifestation of maternal anti-fetal rejection.

Authors:  Kia Lannaman; Roberto Romero; Tinnakorn Chaiworapongsa; Yeon Mee Kim; Steven J Korzeniewski; Eli Maymon; Nardhy Gomez-Lopez; Bogdan Panaitescu; Sonia S Hassan; Lami Yeo; Bo Hyun Yoon; Chong Jai Kim; Offer Erez
Journal:  J Perinat Med       Date:  2017-10-26       Impact factor: 1.901

7.  Human β-defensin-1: A natural antimicrobial peptide present in amniotic fluid that is increased in spontaneous preterm labor with intra-amniotic infection.

Authors:  Aneesha Varrey; Roberto Romero; Bogdan Panaitescu; Derek Miller; Tinnakorn Chaiworapongsa; Manasi Patwardhan; Jonathan Faro; Percy Pacora; Sonia S Hassan; Chaur-Dong Hsu; Nardhy Gomez-Lopez
Journal:  Am J Reprod Immunol       Date:  2018-08-12       Impact factor: 3.886

Review 8.  The Role of Innate Immune System in the Human Amniotic Membrane and Human Amniotic Fluid in Protection Against Intra-Amniotic Infections and Inflammation.

Authors:  Tina Šket; Taja Železnik Ramuta; Marjanca Starčič Erjavec; Mateja Erdani Kreft
Journal:  Front Immunol       Date:  2021-10-21       Impact factor: 7.561

9.  Does the Amniotic Fluid of Mice Contain a Viable Microbiota?

Authors:  Andrew D Winters; Roberto Romero; Jonathan M Greenberg; Jose Galaz; Zachary D Shaffer; Valeria Garcia-Flores; David J Kracht; Nardhy Gomez-Lopez; Kevin R Theis
Journal:  Front Immunol       Date:  2022-02-28       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.